><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book"><collab>World Helath organization</collab>. <source>Global Tuberculosis Report</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2017</year>). Licence: CC BY-NC- SA 3.0 IGO.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Rao</surname><given-names>M</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name><name><surname>Lotze</surname><given-names>M</given-names></name><name><surname>Schito</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review</article-title>. <source>Lancet Respir Med</source> (<year>2014</year>) <volume>2</volume>(<issue>4</issue>):<fpage>301</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/S2213-2600(14)70033-5</pub-id><pub-id pub-id-type="pmid">24717627</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name></person-group>
<article-title>The success and failure of BCG&#x02013; implications for a novel tuberculosis vaccine</article-title>. <source>Nat Rev Microbiol</source> (<year>2005</year>) <volume>3</volume>(<issue>8</issue>):<fpage>656</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro1211</pub-id><pub-id pub-id-type="pmid">16012514</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>PEM</given-names></name></person-group>
<article-title>Variation in protection by BCG: implications of and for heterologues immunity</article-title>. <source>Lancet</source> (<year>1995</year>) <volume>346</volume>:<fpage>1339</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(95)92348-9</pub-id><pub-id pub-id-type="pmid">7475776</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>LC</given-names></name><name><surname>Pereira</surname><given-names>SM</given-names></name><name><surname>Cunha</surname><given-names>SS</given-names></name><name><surname>Genser</surname><given-names>B</given-names></name><name><surname>Ichihara</surname><given-names>MY</given-names></name><name><surname>Brito</surname><given-names>SCD</given-names></name><etal/></person-group>
<article-title>Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial</article-title>. <source>Lancet</source> (<year>2005</year>) <volume>366</volume>(<issue>9493</issue>):<fpage>1290</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/s0140-6736(05)67503-4</pub-id><pub-id pub-id-type="pmid">16214599</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>. <article-title>Novel vaccination strategies against tuberculosis</article-title>. <source>Cold Spring Harb Perspect Med</source> (<year>2014</year>) <volume>4</volume>(<issue>6</issue>):<fpage>a018523</fpage>.<pub-id pub-id-type="doi">10.1101/cshperspect.a018523</pub-id><?supplied-pmid 24890836?><pub-id pub-id-type="pmid">24890836</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahsan</surname><given-names>MJ</given-names></name></person-group>
<article-title>Recent advances in the development of vaccines for tuberculosis</article-title>. <source>Ther Adv Vaccines</source> (<year>2015</year>) <volume>3</volume>(<issue>3</issue>):<fpage>66</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1177/2051013615593891</pub-id><pub-id pub-id-type="pmid">26288734</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Dockrell</surname><given-names>HM</given-names></name><name><surname>Ottenhoff</surname><given-names>THM</given-names></name><name><surname>Evans</surname><given-names>TG</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group>
<article-title>Tuberculosis vaccines: opportunities and challenges</article-title>. <source>Respirology</source> (<year>2018</year>) <volume>23</volume>(<issue>4</issue>):<fpage>359</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1111/resp.13245</pub-id><pub-id pub-id-type="pmid">29341430</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>S</given-names></name><name><surname>Lanni</surname><given-names>F</given-names></name><name><surname>Marinova</surname><given-names>D</given-names></name><name><surname>Rayner</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name></person-group>. <article-title>Revaccination of guinea pigs with the live attenuated <italic>Mycobacterium tuberculosis</italic> vaccine MTBVAC improves BCG&#x02019;s protection against tuberculosis</article-title>. <source>J Infect Dis</source> (<year>2017</year>) <volume>216</volume>(<issue>5</issue>):<fpage>525</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jix030</pub-id><?supplied-pmid 28329234?><pub-id pub-id-type="pmid">28329234</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loxton</surname><given-names>AG</given-names></name><name><surname>Knaul</surname><given-names>JK</given-names></name><name><surname>Grode</surname><given-names>L</given-names></name><name><surname>Gutschmidt</surname><given-names>A</given-names></name><name><surname>Meller</surname><given-names>C</given-names></name><name><surname>Eisele</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Safety and immunogenicity of the recombinant <italic>Mycobacterium bovis</italic> BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa</article-title>. <source>Clin Vaccine Immunol</source> (<year>2017</year>) <volume>24</volume>(<issue>2</issue>):<fpage>e439</fpage>&#x02013;<lpage>416</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00439-16</pub-id><?supplied-pmid 27974398?><pub-id pub-id-type="pmid">27974398</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillard</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>PC</given-names></name><name><surname>Danilovits</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>WJ</given-names></name><name><surname>Cheng</surname><given-names>SL</given-names></name><name><surname>Pehme</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2016</year>) <volume>100</volume>:<fpage>118</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2016.07.005</pub-id><?supplied-pmid 27553419?><pub-id pub-id-type="pmid">27553419</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tameris</surname><given-names>MD</given-names></name><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Landry</surname><given-names>BS</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Snowden</surname><given-names>MA</given-names></name><name><surname>Lockhart</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial</article-title>. <source>Lancet</source> (<year>2013</year>) <volume>381</volume>(<issue>9871</issue>):<fpage>1021</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/s0140-6736(13)60177-4</pub-id><?supplied-pmid 23391465?><pub-id pub-id-type="pmid">23391465</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>Morris</surname><given-names>S</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Achkar</surname><given-names>JM</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The cross-species mycobacterial growth inhibition assay (MGIA) project, 2010&#x02013;2014</article-title>. <source>Clin Vaccine Immunol</source> (<year>2017</year>) <volume>24</volume>(<issue>9</issue>):<fpage>e142</fpage>&#x02013;<lpage>117</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00142-17</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>MK</given-names></name><name><surname>Fletcher</surname><given-names>HA</given-names></name><name><surname>McShane</surname><given-names>H</given-names></name></person-group>. <article-title>In vitro mycobacterial growth inhibition assays: a tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy</article-title>. <source>Vaccine</source> (<year>2016</year>) <volume>34</volume>(<issue>39</issue>):<fpage>4656</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.07.058</pub-id><?supplied-pmid 27527814?><pub-id pub-id-type="pmid">27527814</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>HA</given-names></name><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Manjaly</surname><given-names>ZR</given-names></name><name><surname>Harris</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with <italic>Mycobacterium bovis</italic> BCG</article-title>. <source>Clin Vaccine Immunol</source> (<year>2013</year>) <volume>20</volume>(<issue>11</issue>):<fpage>1683</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1128/cvi.00427-13</pub-id><?supplied-pmid 23986316?><pub-id pub-id-type="pmid">23986316</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>SA</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Satti</surname><given-names>I</given-names></name><name><surname>Marsay</surname><given-names>L</given-names></name><name><surname>Poulton</surname><given-names>ID</given-names></name><name><surname>Tanner</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>209</volume>(<issue>8</issue>):<fpage>1259</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit647</pub-id><?supplied-pmid 24273174?><pub-id pub-id-type="pmid">24273174</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>C</given-names></name><name><surname>Holm</surname><given-names>LL</given-names></name><name><surname>Svensson</surname><given-names>E</given-names></name><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Ruhwald</surname><given-names>M</given-names></name></person-group>. <article-title>Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>(<issue>1</issue>):<fpage>2830</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1038/s41598-017-02116-1</pub-id><?supplied-pmid 28588268?><pub-id pub-id-type="pmid">28588268</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>Stylianou</surname><given-names>E</given-names></name><name><surname>Damelang</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>S</given-names></name><name><surname>Izzo</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>A new tool for tuberculosis vaccine screening: ex vivo mycobacterial growth inhibition assay indicates BCG-mediated protection in a murine model of tuberculosis</article-title>. <source>BMC Infect Dis</source> (<year>2016</year>) <volume>16</volume>:<fpage>412</fpage>.<pub-id pub-id-type="doi">10.1186/s12879-016-1751-4</pub-id><?supplied-pmid 27519524?><pub-id pub-id-type="pmid">27519524</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsay</surname><given-names>L</given-names></name><name><surname>Matsumiya</surname><given-names>M</given-names></name><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>Poyntz</surname><given-names>H</given-names></name><name><surname>Griffiths</surname><given-names>KL</given-names></name><name><surname>Stylianou</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against <italic>Mycobacterium tuberculosis</italic> (<italic>M. tb</italic>)</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2013</year>) <volume>93</volume>(<issue>5</issue>):<fpage>551</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2013.04.007</pub-id><pub-id pub-id-type="pmid">23726784</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>AL</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Kolibab</surname><given-names>K</given-names></name><name><surname>Derrick</surname><given-names>S</given-names></name><name><surname>Cadieux</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Clin Vaccine Immunol</source> (<year>2009</year>) <volume>16</volume>(<issue>7</issue>):<fpage>1025</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00067-09</pub-id><?supplied-pmid 19458207?><pub-id pub-id-type="pmid">19458207</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>MK</given-names></name><name><surname>White</surname><given-names>AD</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Harrington-Kandt</surname><given-names>R</given-names></name><name><surname>Matsumiya</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>:<fpage>43478</fpage>.<pub-id pub-id-type="doi">10.1038/srep43478</pub-id><?supplied-pmid 28256545?><pub-id pub-id-type="pmid">28256545</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SG</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Blitz</surname><given-names>R</given-names></name><name><surname>Fletcher</surname><given-names>HA</given-names></name><name><surname>Dockrell</surname><given-names>HM</given-names></name></person-group>. <article-title>Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following <italic>Mycobacterium bovis</italic> BCG-vaccination of infants</article-title>. <source>Vaccine</source> (<year>2016</year>) <volume>34</volume>(<issue>44</issue>):<fpage>5298</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.09.002</pub-id><?supplied-pmid 27622301?><pub-id pub-id-type="pmid">27622301</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Arend</surname><given-names>SM</given-names></name><name><surname>Prins</surname><given-names>C</given-names></name><name><surname>Oftung</surname><given-names>F</given-names></name><name><surname>Korsvold</surname><given-names>GE</given-names></name><etal/></person-group>
<article-title>Mycobacterial growth inhibition is associated with trained innate immunity</article-title>. <source>J Clin Invest</source> (<year>2018</year>) <volume>128</volume>(<issue>5</issue>):<fpage>1837</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1172/JCI97508</pub-id><?supplied-pmid 29461976?><pub-id pub-id-type="pmid">29461976</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoft</surname><given-names>D</given-names></name><name><surname>Worku</surname><given-names>S</given-names></name><name><surname>Kampmann</surname><given-names>B</given-names></name><name><surname>Whalen</surname><given-names>C</given-names></name><name><surname>Ellner</surname><given-names>J</given-names></name><name><surname>Hirsch</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective <italic>Mycobacterium tuberculosis</italic> immunity</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>186</volume>(<issue>10</issue>):<fpage>1448</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1086/344359</pub-id><?supplied-pmid 12404160?><pub-id pub-id-type="pmid">12404160</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haussinger</surname><given-names>K</given-names></name><name><surname>Ballin</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>HD</given-names></name><name><surname>Bolcskei</surname><given-names>P</given-names></name><name><surname>Dierkesmann</surname><given-names>R</given-names></name><name><surname>Dittrich</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Recommendations for quality standards in bronchoscopy</article-title>. <source>Pneumologie</source> (<year>2004</year>) <volume>58</volume>(<issue>5</issue>):<fpage>344</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1055/s-2004-818406</pub-id><pub-id pub-id-type="pmid">15162262</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jafari</surname><given-names>C</given-names></name><name><surname>Ernst</surname><given-names>M</given-names></name><name><surname>Kalsdorf</surname><given-names>B</given-names></name><name><surname>Greinert</surname><given-names>U</given-names></name><name><surname>Diel</surname><given-names>R</given-names></name><name><surname>Kirsten</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2006</year>) <volume>174</volume>(<issue>9</issue>):<fpage>1048</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200604-465OC</pub-id><pub-id pub-id-type="pmid">16858013</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzmann</surname><given-names>C</given-names></name><name><surname>Ernst</surname><given-names>M</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Sotgiu</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Increased frequencies of pulmonary regulatory T-cells in latent <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Eur Respir J</source> (<year>2012</year>) <volume>40</volume>(<issue>6</issue>):<fpage>1450</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1183/09031936.00214611</pub-id><?supplied-pmid 22441737?><pub-id pub-id-type="pmid">22441737</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brakke</surname><given-names>MK</given-names></name></person-group>
<article-title>Density gradient centrifugation: a new separation technique</article-title>. <source>J Am Chem Soc</source> (<year>1951</year>) <volume>73</volume>:<fpage>1847</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1021/ja01148a508</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brakke</surname><given-names>MK</given-names></name></person-group>
<article-title>Zonal separations by density-gradient centrifugation</article-title>. <source>Arch Biochem Biophys</source> (<year>1953</year>) <volume>45</volume>(<issue>2</issue>):<fpage>275</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/S0003-9861(53)80005-6</pub-id><pub-id pub-id-type="pmid">13081137</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="book"><collab>Oxford Immunotec Ltd</collab>. <source>Manufacturer&#x02019;s Instructions for T-SPOT.TB 8</source>. <publisher-loc>Oxfordshire, Great Britain</publisher-loc>: (<year>2013</year>).</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harboe</surname><given-names>M</given-names></name></person-group>. <article-title>Antigens of PPD, old tuberculin, and autoclaved <italic>Mycobacterium bovis</italic> BCG studied by crossed immunoelectrophoresis</article-title>. <source>Am Rev Respir Dis</source> (<year>1981</year>) <volume>124</volume>:<fpage>80</fpage>&#x02013;<lpage>7</lpage>.<?supplied-pmid 7020505?><pub-id pub-id-type="pmid">7020505</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>RE</given-names></name><name><surname>Black</surname><given-names>GF</given-names></name><name><surname>Nazareth</surname><given-names>B</given-names></name><name><surname>Floyd</surname><given-names>S</given-names></name><name><surname>Stenson</surname><given-names>S</given-names></name><name><surname>Stanley</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Gu&#x000e9;rin vaccination in southern England and northern Malawi</article-title>. <source>Clin Exp Immunol</source> (<year>2006</year>) <volume>146</volume>:<fpage>390</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03222.x</pub-id><pub-id pub-id-type="pmid">17100757</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charlson</surname><given-names>ES</given-names></name><name><surname>Bittinger</surname><given-names>K</given-names></name><name><surname>Haas</surname><given-names>AR</given-names></name><name><surname>Fitzgerald</surname><given-names>AS</given-names></name><name><surname>Frank</surname><given-names>I</given-names></name><name><surname>Yadav</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Topographical continuity of bacterial populations in the healthy human respiratory tract</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2011</year>) <volume>184</volume>(<issue>8</issue>):<fpage>957</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201104-0655OC</pub-id><?supplied-pmid 21680950?><pub-id pub-id-type="pmid">21680950</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwerling</surname><given-names>A</given-names></name><name><surname>Behr</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Brewer</surname><given-names>T</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name></person-group>
<article-title>The BCG World Atlas: a database of global BCG vaccination policies and practices</article-title>. <source>PLoS Med</source> (<year>2011</year>) <volume>8</volume>(<issue>3</issue>):<fpage>e1001012</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001012</pub-id><pub-id pub-id-type="pmid">21445325</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangtani</surname><given-names>P</given-names></name><name><surname>Abubakar</surname><given-names>I</given-names></name><name><surname>Ariti</surname><given-names>C</given-names></name><name><surname>Beynon</surname><given-names>R</given-names></name><name><surname>Pimpin</surname><given-names>L</given-names></name><name><surname>Fine</surname><given-names>PE</given-names></name><etal/></person-group>
<article-title>Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials</article-title>. <source>Clin Infect Dis</source> (<year>2014</year>) <volume>58</volume>(<issue>4</issue>):<fpage>470</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1093/cid/cit790</pub-id><?supplied-pmid 24336911?><pub-id pub-id-type="pmid">24336911</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabri</surname><given-names>M</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Yuk</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Realegeno</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages</article-title>. <source>Sci Transl Med</source> (<year>2011</year>) <volume>3</volume>(<issue>104</issue>):<fpage>104ra102</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3003045</pub-id><?supplied-pmid 21998409?><pub-id pub-id-type="pmid">21998409</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>AR</given-names></name><name><surname>Jolliffe</surname><given-names>DA</given-names></name><name><surname>Hooper</surname><given-names>RL</given-names></name><name><surname>Greenberg</surname><given-names>L</given-names></name><name><surname>Aloia</surname><given-names>JF</given-names></name><name><surname>Bergman</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data</article-title>. <source>BMJ</source> (<year>2017</year>) <volume>356</volume>:<fpage>i6583</fpage>.<pub-id pub-id-type="doi">10.1136/bmj.i6583</pub-id><?supplied-pmid 28202713?><pub-id pub-id-type="pmid">28202713</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coussens</surname><given-names>A</given-names></name><name><surname>Timms</surname><given-names>PM</given-names></name><name><surname>Boucher</surname><given-names>BJ</given-names></name><name><surname>Venton</surname><given-names>TR</given-names></name><name><surname>Ashcroft</surname><given-names>AT</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><etal/></person-group>
<article-title>1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunology</source> (<year>2009</year>) <volume>127</volume>(<issue>4</issue>):<fpage>539</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2567.2008.03024.x</pub-id><?supplied-pmid 19178594?><pub-id pub-id-type="pmid">19178594</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganmaa</surname><given-names>D</given-names></name><name><surname>Munkhzul</surname><given-names>B</given-names></name><name><surname>Fawzi</surname><given-names>W</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Bayasgalan</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>High-dose vitamin D3 during tuberculosis treatment in Mongolia. A randomized controlled trial</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2017</year>) <volume>196</volume>(<issue>5</issue>):<fpage>628</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201705-0936OC</pub-id><?supplied-pmid 28692301?><pub-id pub-id-type="pmid">28692301</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>DH</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name></person-group>. <article-title>Cutting edge: vitamin D-mediated human antimicrobial activity against <italic>Mycobacterium tuberculosis</italic> is dependent on the induction of cathelicidin</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>(<issue>4</issue>):<fpage>2060</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2060</pub-id><?supplied-pmid 17675463?><pub-id pub-id-type="pmid">17675463</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>BH</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><etal/></person-group>
<article-title>Toll-like receptor triggering of a vitamin D&#x02013;mediated human antimicrobial response</article-title>. <source>Science</source> (<year>2006</year>) <volume>311</volume>(<issue>5768</issue>):<fpage>1770</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1126/science.1123933</pub-id><pub-id pub-id-type="pmid">16497887</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group>. <article-title>Persisters, persistent infections and the Yin-Yang model</article-title>. <source>Emerg Microbes Infect</source> (<year>2014</year>) <volume>3</volume>(<issue>1</issue>):<fpage>e3</fpage>.<pub-id pub-id-type="doi">10.1038/emi.2014.3</pub-id><?supplied-pmid 26038493?><pub-id pub-id-type="pmid">26038493</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayigire</surname><given-names>XA</given-names></name><name><surname>Friedrich</surname><given-names>SO</given-names></name><name><surname>van der Merwe</surname><given-names>L</given-names></name><name><surname>Donald</surname><given-names>PR</given-names></name><name><surname>Diacon</surname><given-names>AH</given-names></name></person-group>. <article-title>Simultaneous staining of sputum smears for acid-fast and lipid-containing <italic>Myobacterium tuberculosis</italic> can enhance the clinical evaluation of antituberculosis treatments</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2015</year>) <volume>95</volume>(<issue>6</issue>):<fpage>770</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2015.08.001</pub-id><?supplied-pmid 26318558?><pub-id pub-id-type="pmid">26318558</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peddireddy</surname><given-names>V</given-names></name><name><surname>Doddam</surname><given-names>SN</given-names></name><name><surname>Ahmed</surname><given-names>N</given-names></name></person-group>. <article-title>Mycobacterial dormancy systems and host responses in tuberculosis</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>84</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00084</pub-id><?supplied-pmid 28261197?><pub-id pub-id-type="pmid">28261197</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsburgh</surname><given-names>CR</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name></person-group>
<article-title>Treatment of tuberculosis</article-title>. <source>N Engl J Med</source> (<year>2015</year>) <volume>373</volume>(<issue>22</issue>):<fpage>2149</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMra1413919</pub-id><pub-id pub-id-type="pmid">26605929</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name><name><surname>Desvignes</surname><given-names>L</given-names></name></person-group>. <article-title>Beyond macrophages: the diversity of mononuclear cells in tuberculosis</article-title>. <source>Immunol Rev</source> (<year>2014</year>) <volume>262</volume>(<issue>1</issue>):<fpage>179</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12217</pub-id><?supplied-pmid 25319335?><pub-id pub-id-type="pmid">25319335</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>D</given-names></name><name><surname>Sibley</surname><given-names>L</given-names></name><name><surname>Dennis</surname><given-names>MJ</given-names></name><name><surname>Gooch</surname><given-names>K</given-names></name><name><surname>Betts</surname><given-names>G</given-names></name><name><surname>Edwards</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques</article-title>. <source>Clin Vaccine Immunol</source> (<year>2013</year>) <volume>20</volume>(<issue>5</issue>):<fpage>663</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00690-12</pub-id><?supplied-pmid 23446219?><pub-id pub-id-type="pmid">23446219</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perdomo</surname><given-names>C</given-names></name><name><surname>Zedler</surname><given-names>U</given-names></name><name><surname>Kuhl</surname><given-names>AA</given-names></name><name><surname>Lozza</surname><given-names>L</given-names></name><name><surname>Saikali</surname><given-names>P</given-names></name><name><surname>Sander</surname><given-names>LE</given-names></name><etal/></person-group>
<article-title>Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis</article-title>. <source>MBio</source> (<year>2016</year>) <volume>7</volume>(<issue>6</issue>):<fpage>e1686</fpage>&#x02013;<lpage>1616</lpage>.<pub-id pub-id-type="doi">10.1128/mBio.01686-16</pub-id><?supplied-pmid 27879332?><pub-id pub-id-type="pmid">27879332</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilo</surname><given-names>N</given-names></name><name><surname>Alvarez-Arguedas</surname><given-names>S</given-names></name><name><surname>Uranga</surname><given-names>S</given-names></name><name><surname>Marinova</surname><given-names>D</given-names></name><name><surname>Monzon</surname><given-names>M</given-names></name><name><surname>Badiola</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism</article-title>. <source>J Infect Dis</source> (<year>2016</year>) <volume>213</volume>(<issue>5</issue>):<fpage>831</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiv503</pub-id><pub-id pub-id-type="pmid">26494773</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>(<issue>7309</issue>):<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>DE</given-names></name><name><surname>Penn-Nicholson</surname><given-names>A</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Thompson</surname><given-names>E</given-names></name><name><surname>Suliman</surname><given-names>S</given-names></name><name><surname>Amon</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>A blood RNA signature for tuberculosis disease risk: a prospective cohort study</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>387</volume>(<issue>10035</issue>):<fpage>2312</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(15)01316-1</pub-id><?supplied-pmid 27017310?><pub-id pub-id-type="pmid">27017310</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clifford</surname><given-names>V</given-names></name><name><surname>Tebruegge</surname><given-names>M</given-names></name><name><surname>Zufferey</surname><given-names>C</given-names></name><name><surname>Germano</surname><given-names>S</given-names></name><name><surname>Forbes</surname><given-names>B</given-names></name><name><surname>Cosentino</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis</article-title>. <source>J Infect</source> (<year>2017</year>) <volume>75</volume>(<issue>2</issue>):<fpage>132</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.jinf.2017.04.011</pub-id><?supplied-pmid 28483404?><pub-id pub-id-type="pmid">28483404</pub-id></mixed-citation></ref></